Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Pharmacy Rebates Pdl Gme Dental topic
No spam. Unsubscribe anytime.
Medicaid seeks single preferred drug list, to use rebates for workforce initiatives and expand adult dental services
Summary
Division leaders proposed a single preferred drug list across managed care and fee-for-service, said rebate savings would help fund workforce and graduate medical education initiatives, and outlined an adult dental expansion they say will be cost-effective over time.
Deputy Administrator Jennifer Krupp and Administrator Stacy Weeks outlined plans to centralize pharmacy coverage and use rebate savings to support workforce initiatives, graduate medical education (GME) and certain administrative costs.
Single Preferred Drug List (PDL): Weeks described an initiative to create a single PDL across managed care organizations and fee-for-service to improve consistency for providers and members and to increase rebate maximization. The division plans staff to manage implementation and noted some staffing costs would be covered from the rebate account.
Pharmacy rebate funding and workforce: The administration proposes using increased pharmacy rebate revenue to help fund new workforce initiatives and GME-related supplemental payments. Weeks said part of the requested staffing would be funded from rebate accounts and other non-general-fund sources. Administration witnesses acknowledged that rebate accounting and federal holdback rules require careful treatment and said they would correct technical accounting issues in a future submission.
Oral health and dental expansion: Jennifer Krupp and Lynette Aaron discussed continuation of federal grants for oral-health activities and a request to expand certain adult dental preventive and periodontal services initially; they told lawmakers Mercer actuarial work showed the adult dental expansion yields downstream managed-care savings by reducing emergency and high-cost medical encounters. Lynette Aaron corrected a funding label during Q&A, stating the contracted dental hygienist (E312) is funded from Healthy Nevada funds, not opioid settlement dollars.
Why it matters: Pharmacy rebates and drug-list consolidation can materially affect program savings and how the division funds workforce and new initiatives without increasing general-fund exposure.
Lawmakers asked for a clearer accounting of rebate holdbacks, and Weeks said the administration will provide technical corrections in the upcoming 3245 item and follow-up fiscal detail.
Ending: Jennifer Krupp said the continued pharmacy leadership positions and ARPA-funded staff have improved operations, reducing the division's vacancy rate from 28% to about 8% and enhancing capacity for program changes. "She will be leading the implementation of the single PDL ... and will be leading the implementation of the single preferred drug list," Krupp said of the pharmacy lead role during Q&A.
